Industry Newsdeepminddrug discoveryisomo
Alphabet Launches Isomo To Advance AI Drug Discovery
8.8
Alphabet announced on Nov. 5, 2021 that it is launching a new company, Isomo, to apply DeepMind’s artificial intelligence to pharmaceutical research. The unit will focus on discovering new drugs, developing tools and processes, and exploring AI-driven discovery methods. The move signals Alphabet’s strategic push into biotech and computational drug discovery.
Key Points
- 1Launches Isomo to apply DeepMind AI models toward discovering new drugs and research tools
- 2Seeks to accelerate pharmaceutical R&D by combining AI models with experimental and computational processes
- 3Indicates practitioners should expect new AI-driven drug discovery tools and potential collaboration opportunities
Scoring Rationale
Significant industry-level development driven by Alphabet/DeepMind, but shallow reporting and limited technical detail reduce immediate practitioner utility.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems